| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |